Profil
Scott Filosi is currently the Chief Executive Officer at Diaccurate SA since 2023.
He also holds a current position as the Head-Global Market Access & Pricing at Merck KGaA.
Previously, he worked at Merck KGaA as the Head-Global Market Access & Pricing.
Aktive Positionen von Scott Filosi
| Unternehmen | Position | Beginn |
|---|---|---|
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Vorstandsvorsitzender | 06.11.2023 |
Ehemalige bekannte Positionen von Scott Filosi
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01.05.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Diaccurate SA
Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Health Technology |
